Human-led conference design: why consideration is key to driving home essential messages

Strata’s Head of Pharma Operations, Sally Bradley, discusses why putting delegates front and centre of event design delivers stronger engagement, better recall, and lasting relationships.

A few years ago, I was working on a large-scale pharmaceutical conference for an international client. One of the key opinion leaders (KOLs) on the panel was also a patient advocate, living with the chronic condition he was there to discuss.

On the morning of his session, I knew from managing his travel that he had already been on an eight-hour journey and had not had any time to rest before arriving at the venue. So when I met him, half an hour before he was due on stage, I had water and snacks ready.

Because while the project had high expectations of him as a KOL, he was also a person managing a health condition. I knew that a small moment of consideration could make a meaningful difference, both to his experience and his ability to deliver the session.

That moment has stayed with me because it reflects a wider truth. Healthcare professionals (HCPs) are under increasing pressure, from junior practitioners through to globally recognised KOLs. If we want them to engage, contribute and retain what they learn, we have to respect their time, energy and individuality.

Delegate experience is no longer just a “nice to have”. It directly determines engagement, recall and impact. If the journey feels impersonal or uncomfortable, there is a real risk that even the most important educational messages will not land.

Conference success sits at the intersection of logistics, production and compelling content. Increasingly, operations teams are playing a critical role in shaping that content, ensuring it aligns with where audiences are in the drug lifecycle and how they want to engage. When operational insight is brought into content design, it creates opportunities for more meaningful, human-led experiences.

Once in the room, that human-first approach can transform outcomes. Traditional formats such as long presentations and static panel discussions still have their place, but they are no longer enough on their own. There is a clear opportunity for the pharmaceutical industry to stand out by moving beyond passive, sit-and-listen models.

The most effective conferences I have worked on incorporate:

• Shorter sessions of 20 to 25 minutes to maintain focus
• Incorporating movement and varied formats to sustain energy
• Stand-up discussions, breakouts and structured prompts that encourage dialogue
• Content designed for interaction, not just information delivery

Designing for the individual, rather than the crowd, enables deeper engagement. HCP needs vary significantly depending on their role, experience and position within the drug lifecycle, and events should reflect that diversity.

Smaller forums, such as advisory boards, give delegates a voice and create space for genuine exchange. They also strengthen the networking experience, which remains one of the most compelling reasons for attending live events.

Just as importantly, it is often the smallest touches that leave the biggest impression. Personal acknowledgement, accessibility considerations and thoughtful details all contribute to an experience that feels considered and respectful. These experiences are what drive lasting recall.

When I spoke to that KOL again several years later, he still remembered that moment of consideration and thanked me for it. It’s easy in our industry to focus on trial data, product launches and key messages. But ultimately, events are about relationships. They are platforms for connection, conversation and trust-building.

We are not just engaging today’s delegates. We are nurturing future KOLs and long-term advocates. While content matters, how people are made to feel matters just as much. In the end, delegates may not remember every slide, but they will remember how they were treated. Kindness, empathy and genuine human consideration remain some of the most powerful tools we have.

Sally Bradley is Head of Pharma Operations at Strata. With deep sector expertise, Sally is a skilled project manager with experience with live, virtual and hybrid events.